Astellas Pharma SG&A Expense (Quarterly) Trends

Astellas Pharma Inc (ALPMY)

9.59 +0.12 (+1.27%) USD | OTCM | Apr 25, 09:43

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	1.351B
September 30, 2023	1.241B
June 30, 2023	1.226B
March 31, 2023	1.206B
December 31, 2022	1.156B
September 30, 2022	1.119B
June 30, 2022	1.184B
March 31, 2022	1.226B
December 31, 2021	1.196B
September 30, 2021	1.212B
June 30, 2021	1.253B
March 31, 2021	1.334B
December 31, 2020	1.158B
September 30, 2020	1.144B
June 30, 2020	1.122B
March 31, 2020	1.338B
December 31, 2019	1.173B
September 30, 2019	1.012B
June 30, 2019	1.069B
March 31, 2019	1.221B
December 31, 2018	1.102B
September 30, 2018	1.064B

Date	Value
June 30, 2018	1.035B
March 31, 2018	1.184B
December 31, 2017	1.078B
September 30, 2017	1.046B
June 30, 2017	1.011B
March 31, 2017	1.179B
December 31, 2016	1.061B
September 30, 2016	1.065B
June 30, 2016	1.036B
March 31, 2016	1.195B
December 31, 2015	1.012B
September 30, 2015	991.00M
June 30, 2015	978.22M
March 31, 2015	1.136B
December 31, 2014	1.010B
September 30, 2014	1.009B
June 30, 2014	948.65M
March 31, 2014	1.108B
December 31, 2013	980.71M
September 30, 2013	944.41M
June 30, 2013	922.87M
March 31, 2013	-603.04M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.012B

Minimum

Sep 2019

1.351B

Maximum

Dec 2023

1.196B

Average

1.196B

Median

Dec 2021

SG&A Expense (Quarterly) Benchmarks